RAN and amyotrophic lateral sclerosis: Regardless, drug-induced changes in target composition, as implied by stabilization of RanGTPase in ALS patient blood treated with assembly modulators, is consistent with restoration of homeostasis as a therapeutic outcome of drug treatment.